SCHEMBL415584

SCHEMBL415584

Cc1nnc(Cc2cccc3ccccc23)[nH]1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 4/20 0.53
ADRA2B P18089 4/20 0.53
ADRA2C P18825 4/20 0.53
ALDH1A1 P00352 3/20 0.49
EGFR P00533 1/20 0.47
ERBB2 P04626 1/20 0.47
KDM4E B2RXH2 1/20 0.47
GAA P10253 1/20 0.47
HPGD P15428 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
ADRA1A P35348 3/20 0.46
ADRA1D P25100 2/20 0.46
ADRA1B P35368 2/20 0.46
MAPK1 P28482 2/20 0.45
TAAR1 Q96RJ0 2/20 0.45
CYP2D6 P10635 2/20 0.45
LMNA P02545 1/20 0.45
HTR1A P08908 1/20 0.45
MAPT P10636 1/20 0.45
OPRM1 P35372 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2943483 0.75 ADRA2A (0.55) ADRA2AADRA2BADRA2CALDH1A1KDM4E
SCHEMBL6408244 0.75 POLB (0.60) ALDH1A1KDM4EHPGDSMN1; SMN2MAPK1
SCHEMBL3357872 0.74 ALDH1A1 (0.47) ADRA2AADRA2BADRA2CALDH1A1EGFR
SCHEMBL31305464 0.74 ALDH1A1 (0.47) ADRA2AADRA2BADRA2CALDH1A1EGFR
SCHEMBL1249225 0.73 ADRA2A (0.53) ADRA2AADRA2BADRA2CALDH1A1EGFR
SCHEMBL599659 0.73 CYP2C19 (0.62) ADRA2AADRA2BADRA2CALDH1A1ADRA1A
SCHEMBL29490353 0.73 CYP2C19 (0.62) ADRA2AADRA2BADRA2CALDH1A1ADRA1A
SCHEMBL419212 0.72 GAA (0.48) ALDH1A1GAAHPGDTAAR1POLB
SCHEMBL30583065 0.72 EGFR (0.75) ADRA2AADRA2BADRA2CEGFRERBB2
SCHEMBL2943474 0.72 EGFR (0.75) ADRA2AADRA2BADRA2CEGFRERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120022083-A1 SMALL MOLECULE MODULATORS OF CELL ADHESION ADHEREX TECHNOLOGIES, INC. (CA) 2012-01-26 US claimed
US-20090291967-A1 SMALL MOLECULE MODULATORS OF CELL ADHESION ADHEREX TECHNOLOGIES, INC. (CA) 2009-11-26 US claimed
US-20120022083-A1 SMALL MOLECULE MODULATORS OF CELL ADHESION ADHEREX TECHNOLOGIES, INC. (CA) 2012-01-26 US disclosed
US-20120022083-A1 SMALL MOLECULE MODULATORS OF CELL ADHESION ADHEREX TECHNOLOGIES, INC. (CA) 2012-01-26 US disclosed
US-20120022083-A1 SMALL MOLECULE MODULATORS OF CELL ADHESION ADHEREX TECHNOLOGIES, INC. (CA) 2012-01-26 US disclosed
US-20090291967-A1 SMALL MOLECULE MODULATORS OF CELL ADHESION ADHEREX TECHNOLOGIES, INC. (CA) 2009-11-26 US disclosed
US-20090291967-A1 SMALL MOLECULE MODULATORS OF CELL ADHESION ADHEREX TECHNOLOGIES, INC. (CA) 2009-11-26 US disclosed
US-20090291967-A1 SMALL MOLECULE MODULATORS OF CELL ADHESION ADHEREX TECHNOLOGIES, INC. (CA) 2009-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291967-A1 SMALL MOLECULE MODULATORS OF CELL ADHESION CDH1, EPCAM, ICAM1 ADRA2A 660/4885ADRA2B 775/4885ADRA2C 1436/4885
US-20120022083-A1 SMALL MOLECULE MODULATORS OF CELL ADHESION CDH1, EPCAM, ICAM1 ADRA2A 660/4885ADRA2B 775/4885ADRA2C 1436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.